Literature DB >> 29588704

Determining the Most Appropriate Mode of Coronary Artery Revascularisation in Patients With Diabetes.

Ehrin J Armstrong1, Stephen W Waldo1.   

Abstract

Obstructive coronary artery disease is a common cause of morbidity and mortality among patients with diabetes mellitus (DM). Previous research has demonstrated that the clinical sequelae of coronary artery disease remains the most common cause of death in this population. As a result numerous observational studies and randomised clinical trials have evaluated the timing and mode of coronary artery revascularisation within this population. In this review, we survey the currently available data informing the indications and optimal method of coronary revascularisation for diabetic patients.

Entities:  

Keywords:  Diabetes; coronary artery bypass grafting; coronary artery disease; percutaneous coronary intervention

Year:  2016        PMID: 29588704      PMCID: PMC5808485          DOI: 10.15420/icr.2016:4:2

Source DB:  PubMed          Journal:  Interv Cardiol        ISSN: 1756-1485


  29 in total

Review 1.  Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association.

Authors:  S M Grundy; I J Benjamin; G L Burke; A Chait; R H Eckel; B V Howard; W Mitch; S C Smith; J R Sowers
Journal:  Circulation       Date:  1999-09-07       Impact factor: 29.690

2.  Randomized comparison of everolimus-eluting stent versus sirolimus-eluting stent implantation for de novo coronary artery disease in patients with diabetes mellitus (ESSENCE-DIABETES): results from the ESSENCE-DIABETES trial.

Authors:  Won-Jang Kim; Seung-Whan Lee; Seong-Wook Park; Young-Hak Kim; Sung-Cheol Yun; Jong-Young Lee; Duk-Woo Park; Soo-Jin Kang; Cheol Whan Lee; Jae-Hwan Lee; Si Wan Choi; In-Whan Seong; Bong-Ki Lee; Nae-Hee Lee; Yoon Haeng Cho; Won-Yong Shin; Seung-Jin Lee; Se-Whan Lee; Min-Su Hyon; Duk-Won Bang; Woo-Jung Park; Hyun-Sook Kim; Jei Keon Chae; Keun Lee; Hoon-Ki Park; Chang-Bum Park; Sang-Gon Lee; Min-Kyu Kim; Kyoung-Ha Park; Young-Jin Choi; Sang-Sig Cheong; Tae-Hyun Yang; Jae-Sik Jang; Sung Ho Her; Seung-Jung Park
Journal:  Circulation       Date:  2011-08-01       Impact factor: 29.690

3.  Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial.

Authors:  Friedrich W Mohr; Marie-Claude Morice; A Pieter Kappetein; Ted E Feldman; Elisabeth Ståhle; Antonio Colombo; Michael J Mack; David R Holmes; Marie-angèle Morel; Nic Van Dyck; Vicki M Houle; Keith D Dawkins; Patrick W Serruys
Journal:  Lancet       Date:  2013-02-23       Impact factor: 79.321

4.  A randomized controlled trial in second-generation zotarolimus-eluting Resolute stents versus everolimus-eluting Xience V stents in real-world patients: the TWENTE trial.

Authors:  Clemens von Birgelen; Mounir W Z Basalus; Kenneth Tandjung; K Gert van Houwelingen; Martin G Stoel; J Hans W Louwerenburg; Gerard C M Linssen; Salah A M Saïd; Miep A W J Kleijne; Hanim Sen; Marije M Löwik; Job van der Palen; Patrick M J Verhorst; Frits H A F de Man
Journal:  J Am Coll Cardiol       Date:  2012-02-15       Impact factor: 24.094

5.  Paclitaxel-Eluting versus Everolimus-Eluting Coronary Stents in Diabetes.

Authors:  Upendra Kaul; Sripal Bangalore; Ashok Seth; Priyadarshini Arambam; Rajpal K Abhaichand; Rajpal K Abhaychand; Tejas M Patel; Darshan Banker; Atul Abhyankar; Ajit S Mullasari; Sanjay Shah; Rajneesh Jain; Premchand R Kumar; C G Bahuleyan
Journal:  N Engl J Med       Date:  2015-10-14       Impact factor: 91.245

6.  Effect of screening for coronary artery disease using CT angiography on mortality and cardiac events in high-risk patients with diabetes: the FACTOR-64 randomized clinical trial.

Authors:  Joseph B Muhlestein; Donald L Lappé; Joao A C Lima; Boaz D Rosen; Heidi T May; Stacey Knight; David A Bluemke; Steven R Towner; Viet Le; Tami L Bair; Andrea L Vavere; Jeffrey L Anderson
Journal:  JAMA       Date:  2014-12-03       Impact factor: 56.272

7.  The final 10-year follow-up results from the BARI randomized trial.

Authors: 
Journal:  J Am Coll Cardiol       Date:  2007-04-02       Impact factor: 24.094

8.  Coronary artery bypass graft surgery versus drug-eluting stents for patients with isolated proximal left anterior descending disease.

Authors:  Edward L Hannan; Ye Zhong; Gary Walford; David R Holmes; Ferdinand J Venditti; Peter B Berger; Alice K Jacobs; Nicholas J Stamato; Jeptha P Curtis; Samin Sharma; Spencer B King
Journal:  J Am Coll Cardiol       Date:  2014-12-30       Impact factor: 24.094

9.  Percutaneous coronary intervention versus coronary bypass surgery in United States veterans with diabetes.

Authors:  Masoor Kamalesh; Thomas G Sharp; X Charlene Tang; Kendrick Shunk; Herbert B Ward; James Walsh; Spencer King; Cindy Colling; Thomas Moritz; Kevin Stroupe; Domenic Reda
Journal:  J Am Coll Cardiol       Date:  2013-02-26       Impact factor: 24.094

10.  Paclitaxel-eluting coronary stents in patients with diabetes mellitus: pooled analysis from 5 randomized trials.

Authors:  Ajay J Kirtane; Stephen G Ellis; Keith D Dawkins; Antonio Colombo; Eberhard Grube; Jeffrey J Popma; Martin Fahy; Martin B Leon; Jeffrey W Moses; Roxana Mehran; Gregg W Stone
Journal:  J Am Coll Cardiol       Date:  2008-02-19       Impact factor: 24.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.